Notably, nuclear localization of TAZ was observed in 71.4% (15 of 21) and 77.8% (21 of 27) of LMP1-positive NPC and gastric cancer tissues separately, whereas only 30.6% (15 of 49) and 43.8% (42 of 96) of LMP1-negative NPC and gastric cancer tissues exhibited positive nuclear staining of TAZ respectively (Figure 5C and 5D). The gene discussed is WWTR1; the disease is nasopharyngeal carcinoma.